We are live on ! Find out more
FLAM

First Light Asset Management Portfolio holdings

AUM $1.12B
1-Year Est. Return 114.45%
This Fund
S&P 500
This Quarter Est. Return
+26.49%
1 Year Est. Return
+114.45%
3 Year Est. Return
+266.49%
5 Year Est. Return
+454.92%
10 Year Est. Return
+8,470.94%
AUM
$988M
AUM Growth
+$129M
Cap. Flow
+$16.3M
Cap. Flow %
1.65%
Top 10 Hldgs %
50.06%
Holding
77
New
6
Increased
26
Reduced
14
Closed
6

Top Buys

Rank Stock Value
1
RETA
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
+$29.2M
2
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
+$8.2M
3
LABU icon
Direxion Daily S&P Biotech Bull 3X ETF
LABU
+$7.86M
4
TMDX icon
Transmedics
TMDX
+$6.69M
5
MIRM icon
Mirum Pharmaceuticals
MIRM
+$5.9M

Top Sells

Rank Stock Value
1
PRTA icon
Prothena Corp
PRTA
+$12.6M
2
TPTX
Turning Point Therapeutics, Inc. Common Stock
TPTX
+$10.6M
3
KRYS icon
Krystal Biotech
KRYS
+$7.45M
4
CDXS icon
Codexis
CDXS
+$7.17M
5
CDNA icon
CareDx
CDNA
+$4.87M

Sector Composition

Rank Sector Weight
1 Healthcare 86.29%
2 Communication Services 9.04%
3 Energy 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KRMD icon
26
KORU Medical Systems
KRMD
$189M
$14M 1.42%
6,273,773
+170,839
+3% +$423K
NGM
27
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
$12.5M 1.26%
955,505
-180,379
-16% -$2.73M
HCAT icon
28
Health Catalyst
HCAT
$154M
$11.2M 1.13%
1,149,833
+14,668
+1% +$194K
MIRM icon
29
Mirum Pharmaceuticals
MIRM
$6.46B
$11M 1.11%
522,864
+245,190
+88% +$5.9M
BMRN icon
30
BioMarin Pharmaceuticals
BMRN
$11.6B
$10.5M 1.06%
123,322
+18,509
+18% +$1.65M
BVS icon
31
Bioventus
BVS
$892M
$9.79M 0.99%
1,398,922
+50,462
+4% +$395K
CDNA icon
32
CareDx
CDNA
$2.26B
$9.36M 0.95%
549,797
-226,823
-29% -$4.87M
PHLT
33
DELISTED
Performant Healthcare Inc
PHLT
$9.29M 0.94%
5,020,107
+330
+0% +$767
MXCT icon
34
MaxCyte
MXCT
$112M
$8.86M 0.9%
1,362,543
+43,054
+3% +$240K
PFE icon
35
Pfizer
PFE
$143B
$6.44M 0.65%
147,151
+795
+0.5% +$38.6K
AKU
36
DELISTED
Akumin Inc
AKU
$6.44M 0.65%
3,764,264
– –
TMDX icon
37
Transmedics
TMDX
$2.64B
$6.42M 0.65%
+153,769
New +$6.69M
LABU icon
38
Direxion Daily S&P Biotech Bull 3X ETF
LABU
$506M
$6.01M 0.61%
+42,891
New +$7.86M
ABCM
39
DELISTED
Abcam PLC
ABCM
$5.75M 0.58%
383,557
+162,719
+74% +$2.44M
OPRX icon
40
OptimizeRx
OPRX
$114M
$5.39M 0.55%
364,036
+3,275
+0.9% +$64.7K
GMAB icon
41
Genmab
GMAB
$17.7B
$5.2M 0.53%
161,727
+842
+0.5% +$29.6K
CSTL icon
42
Castle Biosciences
CSTL
$849M
$4.26M 0.43%
+163,224
New +$4.58M
NARI
43
DELISTED
Inari Medical, Inc. Common Stock
NARI
$3.29M 0.33%
45,313
+284
+0.6% +$21.1K
MIRO
44
DELISTED
Miromatrix Medical Inc. Common Stock
MIRO
$2.26M 0.23%
516,007
– –
SLP icon
45
Simulations Plus
SLP
$369M
$1.75M 0.18%
36,061
-39,924
-53% -$2.33M
ELV icon
46
Elevance Health
ELV
$81.5B
$565K 0.06%
1,244
– –
CI icon
47
Cigna
CI
$73.8B
$539K 0.05%
1,943
– –
CVS icon
48
CVS Health
CVS
$133B
$526K 0.05%
5,519
– –
HUM icon
49
Humana
HUM
$43.7B
$518K 0.05%
1,068
– –
BMY icon
50
Bristol-Myers Squibb
BMY
$133B
$516K 0.05%
7,256
– –
1
2
3 4

Similar funds

AIM
Advyzon Investment Management Lisle, Illinois $1.12B AUM 22.08% 1-Year Est. Return
MTCM
Mint Tower Capital Management Amsterdam, Netherlands $1.12B AUM 19.06% 1-Year Est. Return
CNC
Canandaigua National Corp Canandaigua, New York $1.12B AUM
C
Chescapmanager Baltimore, Maryland $1.12B AUM 67.49% 1-Year Est. Return
RIM
Rockbridge Investment Management Syracuse, New York $1.11B AUM 13.62% 1-Year Est. Return
CT
Caldwell Trust Venice, Florida $1.12B AUM 21.31% 1-Year Est. Return
SL
Salomon & Ludwin Richmond, Virginia $1.12B AUM 14.38% 1-Year Est. Return
HH
Hilltop Holdings Dallas, Texas $1.11B AUM 24.7% 1-Year Est. Return

First Light Asset Management's Q3 2022 Portfolio in Review

As of Q3 2022, First Light Asset Management held 77 positions worth $988M, up 15% from $859M the previous quarter. Its ten largest holdings account for 50% of the portfolio.

First Light Asset Management's Q3 2022 filing shows 6 new, 26 increased, 14 reduced and 6 closed positions. Its largest new stake was Reata Pharmaceuticals, Inc. Class A Common Stock: 1,054,985 shares worth $26.5M. The largest sale was Prothena Corp, an estimated $12.6M.

By sector, the portfolio is most concentrated in Healthcare at 86% of assets, down from 87% a quarter earlier, followed by Communication Services and Energy.

  • First Light Asset Management's largest Q3 2022 buy was Reata Pharmaceuticals, Inc. Class A Common Stock: 1,054,985 shares worth $26.5M.
  • First Light Asset Management added most to Karuna Therapeutics, Inc. Common Stock in Q3 2022, an estimated $8.2M increase.
  • First Light Asset Management's biggest Q3 2022 reduction was Prothena Corp, cutting an estimated $12.6M.
  • First Light Asset Management fully exited Turning Point Therapeutics, Inc. Common Stock in Q3 2022, selling an estimated $10.6M.
  • First Light Asset Management's ten largest holdings make up 50% of its $988M portfolio in Q3 2022.
  • First Light Asset Management opened 6 new positions and closed 6 in Q3 2022.
  • First Light Asset Management's portfolio value rose 15% quarter-over-quarter to $988M.

Based on First Light Asset Management's 13F filing for Q3 2022, filed 14 Nov 2022.